BVDV Type 1 and Type 2: Veterinary Reference

Overview and Taxonomy of Bovine Viral Diarrhea Virus Type 1 and Type 2

Bovine Viral Diarrhea Virus (BVDV) represents one of the most economically consequential viral pathogens affecting cattle production systems globally, a status formally recognized by the World Organisation for Animal Health (WOAH) and the Food and Agriculture Organization (FAO) due to its profound impact on reproductive performance, respiratory health, and international trade. The virus is a member of the genus Pestivirus within the family Flaviviridae, a taxonomic grouping it shares with classical swine fever virus (CSFV), border disease virus (BDV) of sheep, and a growing number of emerging pestiviral species [5]. The classification of BVDV into two distinct species, Bovine viral diarrhea virus type 1 (BVDV-1) and Bovine viral diarrhea virus type 2 (BVDV-2), is not merely a taxonomic exercise but reflects fundamental differences in genomic architecture, antigenic properties, virulence potential, and epidemiological behavior that are critical for designing effective control, vaccination, and diagnostic strategies.

Taxonomic Hierarchy and Nomenclatural Considerations

The formal taxonomic framework places BVDV-1 and BVDV-2 within the family Flaviviridae, genus Pestivirus. Historically, these were designated as Pestivirus A (BVDV-1) and Pestivirus B (BVDV-2) under the revised species nomenclature adopted by the International Committee on Taxonomy of Viruses (ICTV). This reclassification was necessitated by accumulating genetic and serological evidence demonstrating that the two types are sufficiently divergent to warrant species-level distinction rather than being mere subtypes of a single virus. The genomic organization of both species is characteristic of pestiviruses, consisting of a single-stranded, positive-sense RNA genome of approximately 12.3 kb that encodes a single polyprotein flanked by highly conserved 5′ and 3′ untranslated regions (UTRs). The 5′ UTR, along with the N-terminal autoprotease (Npro) and the envelope glycoprotein E2, have become the standard genomic regions for phylogenetic differentiation and subtyping [2, 7].

The genetic diversity within BVDV-1 is particularly extensive, with at least 21 recognized subtypes (designated BVDV-1a through BVDV-1u) identified through phylogenetic analysis of the 5′ UTR and Npro sequences. In contrast, BVDV-2 exhibits a comparatively narrower but still significant diversity, with subtypes 2a, 2b, and 2c currently recognized [2, 7]. This disparity in subtype richness likely reflects the longer evolutionary history of BVDV-1 in cattle populations and its broader global dissemination. The two species are estimated to share approximately 70–75% nucleotide sequence identity across the complete genome, a divergence threshold that supports their classification as distinct viral species within the genus.

Historical Context and the Recognition of BVDV-2 as a Distinct Species

The concept of BVDV-2 as a separate species emerged in the early 1990s following the identification of highly virulent BVDV strains in North America that caused severe hemorrhagic disease and high mortality in cattle of all ages, clinical presentations that were atypical for the then-known BVDV-1 strains. Prior to this, all BVDV isolates were considered variants of a single viral species, with antigenic differences attributed to natural strain variation. The recognition of BVDV-2 was catalyzed by phylogenetic analyses of the 5′ UTR, which revealed a distinct genetic cluster that did not align with any known BVDV-1 subtypes. Subsequent studies confirmed that BVDV-2 strains could be further divided into subtypes, with BVDV-2b emerging as a particularly important lineage in certain geographic regions. For instance, a comprehensive survey of pestiviruses in Southern Brazil revealed that BVDV-2b accounted for 42.4% of all BVDV-positive samples from 6- to 12-month-old calves, a proportion markedly higher than that reported in many other cattle-producing regions [2]. This finding underscores the importance of regional surveillance, as the prevalence and subtype distribution of BVDV-2 can vary dramatically across geographic boundaries.

Genetic and Antigenic Distinctions Between BVDV-1 and BVDV-2

The genetic divergence between BVDV-1 and BVDV-2 is most pronounced in the E2 glycoprotein, the major envelope protein responsible for virus attachment, cell entry, and the primary target for neutralizing antibodies. This divergence has direct implications for vaccine efficacy and diagnostic serology. Neutralizing antibodies raised against BVDV-1 strains often exhibit reduced cross-reactivity against BVDV-2, and vice versa, necessitating the inclusion of both species in commercial vaccines to ensure broad protection [3, 8]. The development of a replicon particle vaccine expressing the E2 glycoprotein of BVDV-1b demonstrated that cross-neutralizing titers could be induced against both type 1 and type 2 genotypes following booster vaccination; however, the response was not universally robust across all challenge scenarios [3]. These findings highlight the antigenic complexity within the BVDV-2 species and the need for continuous monitoring of circulating strains to inform vaccine composition.

Serological relationships within the genus Pestivirus are further complicated by the existence of other pestiviral species. Cross-neutralization assays have demonstrated that a novel ovine pestivirus isolated from aborted lamb fetuses in Italy was antigenically more closely related to CSFV than to either BVDV-1 or BVDV-2, a discovery with significant implications for CSFV serological surveillance programs in regions where multiple pestiviruses coexist [5]. This finding emphasizes that serological diagnostic assays must be carefully validated to distinguish between infections caused by different pestiviral species, particularly when BVDV-2 is present in mixed-species farming operations.

Global Distribution, Subtype Diversity, and Epidemiological Drivers

The geographic distribution of BVDV-1 and BVDV-2 subtypes is not uniform, and distinct epidemiological patterns have emerged that reflect livestock trade networks, management practices, and biosecurity measures. In Northern Ireland, a longitudinal study spanning from 1999 to 2011 detected only BVDV-1a and BVDV-1b, with BVDV-1a being the predominant subtype circulating [7]. Notably, BVDV-2 was not detected in any of the sampled animals, suggesting that either the virus has not been introduced or has not become established in this region. The authors hypothesized that the introduction of BVDV-1b into Northern Ireland occurred between 1999 and 2011, likely through the importation of live cattle, a finding that underscores the role of animal movement in the dissemination of new pestiviral variants [7]. Similarly, in Guangdong Province, China, a survey of calf diarrhea cases identified only BVDV-1b, with strains showing close genetic similarity to the Beijing strain, indicating a relatively homogenous subtype distribution in that region [4].

In contrast, regions with high cattle density and intensive international trade exhibit greater subtype diversity. Southern Brazil represents a particularly illustrative example, where BVDV-1a, BVDV-1b, BVDV-1d, and BVDV-2b were all detected within a single survey of 346 herds [2]. The presence of sheep was significantly associated with BVDV infection in that study, raising the possibility of interspecies transmission and highlighting the importance of considering multi-species farming operations in BVDV control programs [2]. The detection of BVDV type 2 in Kazakhstan, the first report of its kind in that country, further demonstrates the expanding known geographic range of this species and the value of molecular surveillance in previously uncharacterized regions [1]. Interestingly, the Kazakhstan study also detected BVDV RNA in forest flies (Hippobosca equina), raising questions about the potential role of hematophagous insects as mechanical vectors for pestivirus transmission [1]. While the vector capacity of these flies remains to be definitively established, their ability to harbor viable BVDV-2 RNA suggests that alternative transmission routes beyond direct animal-to-animal contact may warrant further investigation.

Molecular Detection and Diagnostic Implications for BVDV-2

The differentiation of BVDV-1 from BVDV-2 relies heavily on molecular techniques targeting conserved genomic regions, with the 5′ UTR remaining the gold standard for phylogenetic characterization due to its high degree of conservation within species yet sufficient variability between species [4, 7]. However, the Npro coding region provides additional resolution for subtyping, particularly for distinguishing between closely related BVDV-2 strains [2]. Diagnostic assays must be designed to detect both species with equal sensitivity, as reliance on BVDV-1-specific primers or antigens could result in false-negative results in populations where BVDV-2 predominates. The development of a monoclonal antibody-based blocking ELISA targeting the E2 protein of BVDV-1 demonstrated high specificity and sensitivity for BVDV-1 antibodies but importantly exhibited no cross-reactivity with BVDV-2 positive sera, confirming the antigenic distinctness of the two species and the necessity for species-specific diagnostic tools [6]. This assay, while highly useful for BVDV-1 surveillance, would need to be complemented with a parallel BVDV-2-specific test to provide comprehensive herd-level diagnostics.

Economic and Clinical Significance in the Context of Taxonomy

The taxonomic distinction between BVDV-1 and BVDV-2 is not merely academic but carries profound clinical and economic implications. BVDV-2 strains, particularly those belonging to subtype 2a, have been associated with severe acute disease characterized by thrombocytopenia, hemorrhagic diathesis, high fever, and mortality rates exceeding 30% in some outbreaks. This contrasts with the more typically subclinical or mild clinical presentations of BVDV-1 infections, although significant variation exists within both species. The ability of BVDV-2 to cross the placenta and cause persistent infection in the developing fetus, a hallmark of all pestiviruses, is well established, and the resulting persistently infected (PI) animals serve as the principal reservoir for virus transmission within and between herds. The economic losses attributable to BVDV-2 include decreased reproductive performance, increased calf mortality, reduced milk production, and the costs associated with diagnostic testing, vaccination, and biosecurity measures. These impacts are compounded by the challenges of controlling a virus that exists as a complex of genetically and antigenically diverse species, necessitating a comprehensive approach that integrates vaccination with the identification and elimination of PI animals.

Molecular Pathogenesis of BVDV-1 and BVDV-2 Infection

The molecular pathogenesis of bovine viral diarrhea virus (BVDV) types 1 and 2 represents a complex, multifaceted interplay between viral determinants of virulence, host cellular machinery, and immune system modulation. As members of the genus Pestivirus within the family Flaviviridae, BVDV-1 and BVDV-2 are enveloped, single-stranded, positive-sense RNA viruses that have evolved sophisticated mechanisms to establish persistent infections, evade host immune responses, and induce a spectrum of clinical disease ranging from subclinical infection to fatal mucosal disease [2, 7]. The World Organisation for Animal Health (WOAH) classifies BVDV as a pathogen of significant economic concern, and understanding its molecular pathogenesis is critical for the development of effective control strategies, including vaccination and biosecurity protocols.

Viral Entry and Cellular Tropism

The initial step in BVDV infection is the attachment and entry into susceptible host cells, a process mediated primarily by the viral envelope glycoprotein E2. The E2 protein is the major immunodominant protein and the primary target for neutralizing antibodies [3, 6]. The molecular interaction between E2 and host cell receptors, including CD46 and other unidentified co-receptors, facilitates viral attachment and subsequent clathrin-mediated endocytosis. Following internalization, the low pH of the endosome triggers conformational changes in the viral glycoproteins, leading to fusion of the viral and endosomal membranes and release of the viral genome into the cytoplasm. The E2 protein exhibits significant genetic diversity between BVDV-1 and BVDV-2, as well as among subtypes (e.g., BVDV-1a, -1b, -1d, and BVDV-2b), which contributes to differences in cellular tropism, host range, and antigenic variation [2, 7]. This genetic variability poses a substantial challenge for vaccine development, as immunity induced against one subtype may not confer complete protection against heterologous strains [3].

Genome Replication and Viral Protein Processing

Once the viral RNA is released into the cytoplasm, it serves as a template for both translation and replication. The BVDV genome is approximately 12.3 kb in length and contains a single open reading frame flanked by highly structured 5′ and 3′ untranslated regions (UTRs). The 5′ UTR is particularly critical for cap-independent translation initiation mediated by an internal ribosome entry site (IRES). This region is also the primary target for molecular detection and genotyping of BVDV, as it contains conserved and variable domains that allow for phylogenetic classification [2, 4, 7]. The viral polyprotein is co- and post-translationally processed by viral and host proteases into structural proteins (C, Erns, E1, E2) and nonstructural proteins (Npro, p7, NS2-3, NS4A, NS4B, NS5A, NS5B). The nonstructural protein Npro is a unique autoprotease that not only cleaves itself from the polyprotein but also plays a pivotal role in immune evasion by targeting the host interferon regulatory factor 3 (IRF3) for proteasomal degradation, thereby suppressing the type I interferon response. This interferon antagonism is a hallmark of BVDV pathogenesis and is essential for the establishment of persistent infection.

Mechanisms of Immune Evasion and Persistent Infection

The ability of BVDV to establish persistent infection is arguably its most devastating pathogenic feature. Infection of a pregnant dam between approximately 30 and 125 days of gestation, before the fetal immune system is fully immunocompetent, results in the birth of a persistently infected (PI) calf that is immunotolerant to the virus. These PI animals shed large quantities of virus throughout their lives and serve as the primary reservoir for transmission within and between herds [2, 7]. At the molecular level, immunotolerance is achieved through the deletion or anergy of virus-specific B and T cell clones during fetal development. The virus's ability to suppress interferon induction via Npro is critical during this period, as it prevents the establishment of an antiviral state that would otherwise trigger fetal immune responses. Furthermore, BVDV can infect and modulate the function of antigen-presenting cells, including dendritic cells and macrophages, impairing their ability to present viral antigens effectively and thus dampening the adaptive immune response.

Cytopathic and Noncytopathic Biotypes

A defining feature of BVDV pathogenesis is the existence of two biotypes: noncytopathic (ncp) and cytopathic (cp). The ncp biotype is the most common form found in nature and is responsible for establishing both acute and persistent infections. The cp biotype arises from ncp viruses through specific molecular alterations, most commonly involving the insertion of host cellular sequences (e.g., ubiquitin or Jiv) into the NS2-3 gene region, or through duplication and rearrangement of viral sequences. These insertions or duplications facilitate the cleavage of NS2-3 into NS2 and NS3 by cellular proteases. The presence of free NS3 is the molecular hallmark of the cp biotype and is directly associated with the induction of apoptosis in infected cells. The emergence of a cp BVDV strain in an animal already persistently infected with an antigenically homologous ncp strain is the molecular trigger for the development of fatal mucosal disease (MD). This process, known as homologous recombination or mutation, leads to widespread cytopathic infection of the intestinal epithelium and lymphoid tissues, resulting in severe diarrhea, ulceration, and death.

Virulence Determinants and Strain-Specific Pathogenesis

Significant differences in virulence exist between BVDV-1 and BVDV-2, as well as among strains within each genotype. BVDV-2 strains, particularly those belonging to the 2a and 2b subtypes, are often associated with more severe acute disease, including severe thrombocytopenia, leukopenia, hemorrhagic syndrome, and high mortality rates in immunocompetent cattle [2]. The molecular basis for this enhanced virulence is multifactorial and involves differences in the efficiency of viral replication, the ability to suppress host interferon responses, and the capacity to induce apoptosis in immune cells. Comparative genomic analyses have identified specific amino acid residues in the E2 glycoprotein and the NS5A protein that correlate with increased virulence. For instance, highly virulent BVDV-2 strains often exhibit more efficient replication in lymphoid tissues, leading to profound lymphopenia and immunosuppression, which predisposes animals to secondary bacterial infections. The ability of BVDV to induce leukopenia is a key clinical feature and is directly related to the virus's tropism for and destruction of circulating white blood cells, including lymphocytes, monocytes, and granulocytes [3].

Impact on Host Cell Signaling and Apoptosis

BVDV infection profoundly alters host cell signaling pathways to favor viral replication and survival. The virus modulates the phosphatidylinositol 3-kinase (PI3K)/Akt pathway, which promotes cell survival and inhibits apoptosis, allowing for prolonged viral production. However, in cp BVDV infection, the accumulation of free NS3 triggers the unfolded protein response (UPR) and endoplasmic reticulum (ER) stress, ultimately leading to the activation of caspases and apoptotic cell death. This differential regulation of cell death pathways, inhibition of apoptosis in ncp infection versus induction of apoptosis in cp infection, is central to the distinct pathogenic outcomes. Furthermore, BVDV infection can induce the production of pro-inflammatory cytokines and chemokines, contributing to the clinical signs of acute disease, including fever and diarrhea. The inflammatory profile associated with BVDV infection, while not as extensively characterized as in human viral diseases, likely involves the activation of NF-κB and the subsequent expression of interleukin-6 (IL-6), tumor necrosis factor-alpha (TNF-α), and other mediators that contribute to systemic inflammation and tissue damage.

Genetic Diversity and Emergence of New Strains

The high mutation rate of the RNA-dependent RNA polymerase, combined with the large population of PI animals that continuously shed virus, drives the genetic and antigenic diversity of BVDV. Phylogenetic analyses have identified at least 21 subtypes of BVDV-1 (1a–1u) and 4 subtypes of BVDV-2 (2a–2d) globally [2, 7]. This diversity has significant implications for diagnosis and control. Diagnostic assays, such as RT-PCR targeting the 5′ UTR, must be designed to detect all circulating subtypes, and vaccines must provide broad cross-protection [6]. The emergence of new subtypes, such as the detection of BVDV-2b in Southern Brazil at a higher frequency than previously reported, highlights the dynamic nature of BVDV evolution and the need for continuous molecular surveillance [2]. The movement of live animals, including the importation of cattle, is a well-documented mechanism for the introduction of new BVDV strains into naive populations, as demonstrated by the introduction of BVDV-1b into Northern Ireland [7]. The role of wildlife and other ruminant species, such as sheep, as reservoirs for BVDV transmission is also increasingly recognized, complicating eradication efforts [2, 9]. The detection of BVDV RNA in hematophagous insects like Hippobosca equina (forest flies) raises the possibility of mechanical or biological vector-borne transmission, although the vector capacity of these insects requires further investigation [1].

Pathogenesis of Co-infections and Secondary Complications

BVDV is a well-known immunosuppressive agent, and its pathogenesis is often exacerbated by concurrent infections with other respiratory or enteric pathogens. BVDV-induced leukopenia and impaired function of alveolar macrophages and neutrophils predispose cattle to secondary bacterial pneumonia caused by Mannheimia haemolytica or Pasteurella multocida, a condition known as bovine respiratory disease complex (BRDC). Similarly, enteric co-infections with bovine rotavirus, bovine coronavirus, or Escherichia coli can lead to more severe diarrhea in calves [4]. The molecular mechanisms underlying this immunosuppression include the direct infection and depletion of CD4+ and CD8+ T lymphocytes, the suppression of major histocompatibility complex (MHC) class II expression on antigen-presenting cells, and the induction of apoptosis in lymphoid follicles of the gut-associated lymphoid tissue (GALT). This profound immunosuppression not only increases the severity of primary BVDV infection but also compromises the efficacy of vaccines against other pathogens, making BVDV control a cornerstone of overall herd health management.

Molecular Basis of Transplacental Transmission and Fetal Pathology

The ability of ncp BVDV to cross the placenta and infect the developing fetus is a critical aspect of its pathogenesis. The virus likely infects the placenta through infected maternal leukocytes or by direct cell-to-cell spread. Once in the fetal circulation, BVDV exhibits a broad tropism for fetal tissues, including the central nervous system, lymphoid organs, and the gastrointestinal tract. The timing of fetal infection determines the outcome: infection before approximately 100 days of gestation leads to persistent infection and immunotolerance; infection between 100 and 150 days can result in abortion, stillbirth, or congenital malformations, including cerebellar hypoplasia, ocular defects, and skeletal abnormalities; infection after 150 days typically results in a transient infection with the development of a protective immune response. The molecular mechanisms underlying these different outcomes are related to the developmental stage of the fetal immune system and the ability of the virus to modulate interferon responses. The Npro protein's ability to block interferon production is particularly critical for establishing persistent infection in the fetus, as it prevents the activation of innate immune pathways that would otherwise clear the virus.

Epidemiology and Transmission Dynamics of BVDV Type 1 and Type 2

Bovine viral diarrhea virus (BVDV) exists as two distinct species within the Pestivirus genus of the Flaviviridae family: Pestivirus A (BVDV-1) and Pestivirus B (BVDV-2). These pathogens impose a staggering economic burden on the global cattle industry, with losses stemming from reproductive failure, respiratory disease, immunosuppression, growth retardation, and mortality. The World Organisation for Animal Health (WOAH) lists BVDV as a key notifiable pathogen in many regions, underscoring its profound significance for international trade and animal health. Understanding the nuanced epidemiology and transmission dynamics of these two genotypes is not merely an academic exercise; it is the critical foundation upon which effective surveillance, biosecurity protocols, and vaccination strategies must be built. The following analysis delves into the global distribution of BVDV-1 and BVDV-2, their genetic diversity, the intricate mechanisms of their spread, and the evolving recognition of their host range and ecological niches.

Global Distribution, Genotypic Diversity, and Emerging Hotspots

The distribution of BVDV-1 and BVDV-2 is not uniform, exhibiting significant geographical variation that reflects historical introductions, livestock movement patterns, and the specific control measures employed by individual nations. BVDV-1 remains the more globally ubiquitous genotype, having been detected on every continent where cattle are raised. It has been further subdivided into numerous subtypes (1a through at least 1p), with BVDV-1a and BVDV-1b being the most prevalent and frequently isolated from clinical cases worldwide [7]. A long-term phylogenetic study in Northern Ireland demonstrated that BVDV-1a had been the dominant circulating subtype for decades, but the introduction of BVDV-1b was linked directly to the importation of live cattle, providing a stark example of how global trade can reshape the local viral landscape [7]. Similarly, epidemiological surveillance in Guangdong Province, China, identified that all BVDV strains circulating in calf diarrhea cases were of the 1b subtype, showing a close genetic relationship to strains isolated in Beijing, suggesting a pattern of domestic viral dissemination [4].

BVDV-2, while less prevalent globally than BVDV-1, has emerged as a pathogen of paramount importance in specific regions, often associated with more severe, acute clinical disease and hemorrhagic syndromic. A landmark study in Southern Brazil reported a remarkably high frequency of BVDV-2, accounting for 42.4% of all positive samples from a large-scale survey of 9,078 calves [2]. This finding contrasts sharply with many other countries where BVDV-2 is a minority genotype, and it forces a re-evaluation of the assumption that BVDV-1 is always the dominant threat. The Brazilian study further revealed that the presence of sheep on farms was a significant risk factor for BVDV infection, highlighting the critical role of multi-species farming in the maintenance and transmission of ruminant pestiviruses [2]. In a historic case for Central Asia, BVDV-2 was molecularly detected and characterized for the first time in Kazakhstan, found in forest flies (Hippobosca equina) collected from livestock [1]. This detection not only expands the known geographic range of BVDV-2 deep into the Asian steppe but also introduces a potential, previously overlooked vector for mechanical transmission. These data collectively indicate that BVDV-2 is not a static pathogen confined to the Americas; it is a dynamic and expanding threat that necessitates continuous global genomic surveillance.

Host Range, Interspecies Transmission, and the Pestivirus Continuum

The transmission dynamics of BVDV are profoundly complicated by its ability to infect not only cattle but also a wide range of domestic and wild ruminants, as well as swine. This promiscuity creates a complex multi-host reservoir system that can thwart control efforts focused solely on cattle. Serological evidence from domestic sheep in Wyoming revealed a 5.6% overall pestivirus antibody prevalence, with the highest antibody titers directed against BVDV-1 [9]. This indicates that sheep and cattle populations are not immunologically isolated; cross-species transmission events occur, and sheep may serve as a silent reservoir for BVDV-1, potentially reintroducing the virus into BVDV-free cattle herds [2, 9]. The risk is not theoretical, as the presence of sheep was statistically associated with BVDV infection in Brazilian herds [2].

Furthermore, the pestivirus envelope is highly diverse, and novel strains continue to emerge. A highly divergent ovine pestivirus isolated from aborted lamb fetuses in Italy was found to be genetically and antigenically more closely related to classical swine fever virus (CSFV) than to BVDV-1 or BVDV-2 [5]. This finding has profound implications for CSFV surveillance and swine health management, as cross-reactive antibodies from this novel ovine pestivirus could confound serological surveillance programs for CSFV, a WOAH-listed disease [5]. It underscores that the boundaries between pestivirus species are permeable and that the epidemiology of BVDV cannot be considered in isolation from the broader ecology of the Pestivirus genus.

Primary Routes of Transmission: Horizontal and Vertical Pathways

The transmission of BVDV is driven by two fundamental and complementary pathways: horizontal transmission via direct or indirect contact and the uniquely efficient vertical transmission that generates persistently infected (PI) animals.

Horizontal transmission occurs primarily through the fecal-oral and oronasal routes. An acutely infected animal, which experiences a transient infection lasting 10–14 days, sheds large quantities of virus in all secretions and excretions, including saliva, nasal discharge, urine, feces, and semen. This creates a high concentration of virus in the environment, rapidly contaminating water troughs, feed bunks, bedding, and fomites. Direct nose-to-nose contact between infected and naïve animals is the most efficient route. Mechanical vectors are also under investigation. The detection of BVDV-2 RNA in 2.88% of H. equina (forest flies) collected from livestock in Kazakhstan raises the possibility that hematophagous insects could serve as mechanical vectors, transmitting the virus between animals during blood feeding, particularly in regions with high ectoparasite burdens [1]. While the vector competence of these flies requires further experimental confirmation, their role as potential sentinel tools for xenodiagnosis is an innovative avenue for epidemiological monitoring.

Vertical transmission is the most insidious and epidemiologically critical route for the perpetuation of BVDV. It occurs when a pregnant, immunologically naïve dam is exposed to the virus during a critical window of gestation, typically between days 30 and 125. The fetal immune system is immature and cannot recognize the virus as foreign, leading to the birth of a calf that is immunotolerant to the infecting strain and remains persistently infected for life. These PI calves are the cornerstone of BVDV transmission dynamics. They shed extraordinarily high concentrations of virus, orders of magnitude higher than acutely infected animals, for their entire lifespan, serving as a continuous source of infection for herdmates. A single PI animal can infect an entire naïve herd in a matter of weeks. The identification and removal of these PI carriers is the single most effective intervention in any BVDV control program.

Biosecurity and Spatial Dynamics: The Role of Livestock Movement

The movement of live animals, particularly the introduction of replacement heifers, breeding bulls, or stocker calves from external sources, represents the most common route for the introduction of BVDV into a naïve or negative herd. The phylogenetic study from Northern Ireland provided direct evidence for this, demonstrating that imported cattle introduced the BVDV-1b subtype into a population that was previously dominated by BVDV-1a [7]. The study found that 18 of 839 imported bovine samples tested positive for BVDV RNA, and the resulting sequences clustered with BVDV-1b strains [7]. This illustrates that even with routine testing, a small number of acutely or persistently infected animals can slip through pre-movement screening and seed a new outbreak.

Local spatial dynamics also play a role. The high prevalence of BVDV-2 in Southern Brazil was linked not only to multi-species farming but also to farm density and management practices [2]. Similarly, a study on data reporting in the French bovine surveillance system highlighted that local organization of veterinarians, farmers, and diagnostic laboratories significantly influences the quality of surveillance data, with variations in abortion declaration rates between departments having similar farming characteristics [10]. This indicates that the human dimension of epidemiology, the local network of trust, competition, and communication between actors, directly impacts our ability to detect and track BVDV transmission.

The development of sophisticated diagnostic tools, such as the monoclonal antibody-based blocking ELISA for detecting antibodies against the BVDV-1 E2 protein, now allows for DIVA (Differentiating Infected from Vaccinated Animals) strategies, which are essential for monitoring vaccine efficacy and understanding true infection dynamics in vaccinated populations [6]. These tools, combined with rigorous biosecurity, swift removal of PI animals, and genomic surveillance of circulating strains, provide the only viable path toward the regional and eventually global control of BVDV-1 and BVDV-2.

Clinical Manifestations and Disease Outcomes in Cattle

Spectrum of Clinical Disease: From Subclinical to Fatal

Bovine viral diarrhea virus (BVDV) infection in cattle presents a remarkably heterogeneous clinical picture, ranging from completely inapparent infections to rapidly fatal hemorrhagic disease. This variability is governed by a complex interplay of viral factors, including genotype (BVDV-1 versus BVDV-2), viral biotype (cytopathic versus noncytopathic), and strain virulence, alongside host factors such as immune status, age, pregnancy status, and the presence of concurrent infections. The classical distinction between BVDV-1 and BVDV-2, while genetically grounded, has profound clinical implications, as BVDV-2 strains are frequently associated with more severe acute disease, particularly thrombocytopenia and hemorrhagic manifestations [2]. Indeed, epidemiological investigations in Southern Brazil have documented a strikingly high frequency of BVDV-2 (42.4% of detected isolates) compared to other global regions, a finding that underscores the regional variability in genotype distribution and the consequent clinical impact on cattle populations [2].

Acute Postnatal Infection: Clinical Trajectories

In immunocompetent, postnatally infected cattle, the clinical course of acute BVDV infection is typically mild or subclinical, with transient fever, mild leukopenia, and subtle reductions in milk production or weight gain being the most consistent findings. However, infection with high-virulence strains, disproportionately represented among BVDV-2 isolates, can precipitate a severe acute syndrome characterized by profound leukopenia, high fever, severe diarrhea, and nasal and ocular discharge. The hematological hallmarks of acute BVDV infection include a significant leukopenia, primarily due to lymphopenia and neutropenia, which serves as both a diagnostic indicator and a contributor to the immunosuppressive state that predisposes animals to secondary bacterial and viral infections [3]. Experimental challenge studies utilizing replicon particle vaccines expressing the E2 glycoprotein have demonstrated that vaccination can significantly reduce the degree of leukopenia and mitigate clinical disease following virulent BVDV challenge, underscoring the central role of the E2 glycoprotein in protective immunity and the clinical consequences of its absence [3].

The most severe acute manifestation, occasionally termed "severe acute BVDV" or "hemorrhagic syndrome," is characterized by thrombocytopenia, petechial and ecchymotic hemorrhages on mucosal surfaces (including the oral cavity, nasal passages, and conjunctiva), epistaxis, bloody diarrhea, and hematuria. This syndrome, while not exclusive to BVDV-2, is most commonly associated with high-virulence BVDV-2 strains and carries a high case-fatality rate. The pathogenesis involves direct viral infection of megakaryocytes and platelets, leading to impaired thrombopoiesis and consumption coagulopathy. Mortality can approach 50% in affected herds, with death occurring within days of the onset of clinical signs. It is critical for veterinary clinicians to differentiate this presentation from other hemorrhagic diseases of cattle, such as bovine anaplasmosis, acute leptospirosis, or anticoagulant rodenticide toxicosis, particularly in regions where BVDV-2 is endemic [2].

Reproductive Manifestations and Fetal Outcomes

The reproductive sequelae of BVDV infection constitute the most economically devastating dimension of the disease, as the virus exhibits a pronounced tropism for fetal tissues and the reproductive tract. The clinical outcome of fetal infection is exquisitely dependent upon the gestational stage at which infection occurs. Infection during the first 40–120 days of gestation, prior to the establishment of fetal immunocompetence, results in the birth of persistently infected (PI) calves that are immunotolerant to the infecting viral strain. These PI animals are the linchpin of BVDV epidemiology, serving as lifelong shedders of large quantities of virus and the primary mechanism for maintaining viral circulation within and between herds. PI calves may appear clinically normal at birth, but they frequently exhibit poor growth rates, increased susceptibility to respiratory and enteric diseases, and a markedly elevated risk of developing mucosal disease later in life. The serological landscape of pestivirus exposure in cattle populations, as revealed by comparative virus neutralization assays, indicates that BVDV-1 is the most frequently detected species, highlighting its dominant role in ongoing reproductive transmission cycles [9].

Infection during mid-gestation (approximately 80–150 days) can result in abortion, stillbirth, or the birth of weak, ill-thrifty calves with congenital defects. The most characteristic congenital anomalies associated with BVDV infection include cerebellar hypoplasia (resulting in ataxia, intention tremors, and a wide-based stance), ocular defects (microphthalmia, cataracts, retinal dysplasia), and brachygnathism (undershot jaw). Infection in the late gestational period typically produces no fetal pathology, as the immunocompetent fetus is capable of mounting a neutralizing antibody response, clearing the virus, and being born as a healthy, seropositive calf. The complex interplay of BVDV with other reproductive pathogens is highlighted by co-infection studies, which have identified BVDV as one of six major viral agents contributing to calf diarrhea in regions of China, with a detection rate of 2.03% among diarrheic calves [4]. This underscores the virus's role in neonatal morbidity beyond its classic reproductive and respiratory presentations.

Mucosal Disease: The Fatal Interaction

Mucosal disease (MD) represents the terminal, invariably fatal consequence of BVDV infection in PI animals. The pathogenesis is rooted in the emergence of a cytopathic (cp) BVDV strain from the persisting noncytopathic (ncp) population, either through spontaneous mutation or, more frequently, through superinfection with a homologous cp strain. The molecular mechanism involves RNA recombination events, leading to the insertion of host-derived sequences (often from cellular ubiquitin genes) into the viral genome, resulting in the production of a functional NS3 protein that is the hallmark of cp biotypes. Clinically, MD is characterized by the acute onset of severe, watery to hemorrhagic diarrhea, high fever, anorexia, profound depression, and profuse salivation. Oral lesions, erosion and ulceration of the dental pad, tongue, gingiva, and esophagus, are pathognomonic and may be so severe as to prevent prehension of feed, leading to rapid dehydration and emaciation. Intestinal involvement leads to hemorrhagic enteritis, with hemorrhagic feces and straining (tenesmus) commonly observed. Death typically ensues within days to two weeks of the onset of clinical signs, with a case-fatality rate approaching 100%. The occurrence of MD in a herd signals the presence of at least one PI animal and represents a sentinel event demanding immediate biosecurity intervention.

Immunosuppression and Viral Interactions

Beyond its direct cytopathic effects, BVDV is a master of immunomodulation. The virus infects and depletes immune cells, including lymphocytes, monocytes, and dendritic cells, leading to a transient but profound immunosuppression that predisposes cattle to secondary infections, particularly of the respiratory tract. This phenomenon is so well-recognized that BVDV is considered a primary component of the bovine respiratory disease complex (BRDC), often acting in synergy with Mannheimia haemolytica, Pasteurella multocida, and Histophilus somni to precipitate severe fibrinous pneumonia. The lymphopenic and neutropenic effects of acute BVDV infection are directly correlated with the severity of clinical disease and the degree of viral replication [3]. Furthermore, the virus's ability to modulate interferon responses and impair antigen presentation contributes to the establishment and maintenance of persistent infection, as well as the exacerbation of concurrent viral infections such as bovine herpesvirus-1 (BoHV-1) and bovine respiratory syncytial virus (BRSV). The development of multivalent vaccines incorporating BVDV alongside BoHV-1, BPI3V, and BRSV, using novel stabilizers like carbomer and adjuvants such as saponin, has been shown to elicit robust and durable neutralizing antibody responses lasting up to nine months, providing a practical tool for controlling the immunosuppressive and respiratory consequences of BVDV infection in field settings [8].

Hemorrhagic and Thrombocytopenic Disease in BVDV-2

As previously noted, BVDV-2 strains, particularly those belonging to the 2b subtype [2], are disproportionately associated with a severe hemorrhagic syndrome that is clinically and pathologically distinct from the more common enteric form. In addition to petechial hemorrhages, infected animals may exhibit severe thrombocytopenia (platelet counts often falling below 50,000/μL), prolonged bleeding from injection sites, and spontaneous hemorrhage into the anterior chamber of the eye (hyphema). The mortality rate in acute outbreaks can be alarmingly high, affecting all age groups within a herd. Postmortem findings include widespread serosal and mucosal hemorrhages, pulmonary edema, and evidence of disseminated intravascular coagulation (DIC). This presentation has been increasingly recognized in countries such as Brazil, where BVDV-2 constitutes a substantial proportion of circulating strains, necessitating heightened vigilance and the inclusion of BVDV-2 antigens in regional vaccination protocols [2]. The global distribution of BVDV-2, including recent molecular detection in forest flies (Hippobosca equina) in Kazakhstan [1], raises concerns about vector-borne mechanical transmission and the potential for introduction of virulent BVDV-2 strains into previously naïve cattle populations, a scenario that could precipitate catastrophic disease outbreaks.

Diagnostic Approaches for BVDV Type 1 and Type 2 Detection

The accurate and timely detection of bovine viral diarrhea virus (BVDV) types 1 and 2 is foundational to any effective control or eradication program. Given the virus’s capacity for transplacental transmission, the generation of persistently infected (PI) animals, and the significant economic burden it imposes on the global cattle industry, diagnostic strategies must be both sensitive and specific. Furthermore, the antigenic and genetic diversity between BVDV-1 and BVDV-2, as well as their numerous subtypes, necessitates a multi-modal diagnostic approach that can reliably differentiate these viral types from each other and from other closely related pestiviruses, such as border disease virus (BDV) and classical swine fever virus (CSFV). The diagnostic arsenal for BVDV has evolved considerably, moving from classical virological methods to highly sensitive molecular techniques and sophisticated serological assays, each with distinct applications in surveillance, acute outbreak investigation, and PI animal identification.

Molecular Detection: RT-PCR and Genotyping

Reverse transcription polymerase chain reaction (RT-PCR) has become the gold standard for the direct detection of BVDV nucleic acid, offering unparalleled sensitivity and speed. This technique is particularly critical for identifying PI animals, where viral RNA is present in serum or tissue samples at high and consistent levels. The 5' untranslated region (5' UTR) of the pestivirus genome is the most common target for RT-PCR assays due to its high degree of conservation among BVDV strains, yet it contains enough sequence variability to allow for downstream genotyping. This target region is central to both diagnostic detection and phylogenetic characterization. For instance, PCR screening of the 5' UTR has been instrumental in revealing the circulation of specific subtypes, such as the unexpectedly high frequency of BVDV-2b in Southern Brazil, which constituted over 42% of positive isolates in a large-scale study of over 9,000 calves [2]. Similarly, phylogenetic analysis of a 288-base pair portion of the 5' UTR has been used to track the introduction of new subtypes, such as BVDV-1b, into regions like Northern Ireland, demonstrating the role of live animal imports in shaping viral diversity [7].

The power of PCR extends beyond conventional blood or serum testing. It has been successfully applied to non-invasive and non-traditional sample types, expanding the scope of surveillance. A notable example is the use of molecular detection in ectoparasites. In a study from southern Kazakhstan, RT-PCR screening of homogenates from forest flies (Hippobosca equina) yielded positive results for BVDV type 2, marking the first report of this viral type in the country [1]. This approach, often termed xenodiagnosis, offers a promising, albeit still experimental, method for monitoring viral circulation in livestock populations without direct animal handling. Furthermore, multiplex RT-PCR panels are now standard in diagnostic laboratories investigating the etiology of bovine respiratory disease complex (BRDC) and neonatal diarrhea. These panels simultaneously detect BVDV along with other major pathogens, including bovine coronavirus (BCoV), bovine rotavirus (BRV), and bovine enterovirus (BEV), providing a comprehensive etiological picture in a single test [4]. The high sensitivity of PCR, however, requires rigorous quality control to avoid false positives from contamination, and the detection of viral RNA does not always distinguish between active replication and residual nucleic acid from a cleared infection or vaccine origin.

Virus Isolation and Antigen Detection

Virus isolation (VI) in cell culture remains a definitive, albeit slower, method for BVDV detection. It is essential for obtaining viral isolates for further antigenic characterization, vaccine matching, and research purposes. BVDV is typically non-cytopathic (ncp) in cell culture, requiring detection via immunoperoxidase or immunofluorescence staining using specific monoclonal antibodies after several days of incubation. The primary advantage of VI is the provision of a live virus stock, but it is significantly less sensitive than RT-PCR, more labor-intensive, and can be hampered by sample toxicity or the presence of neutralizing antibodies in the sample. For this reason, VI is often used in conjunction with, or as a confirmatory test for, PCR-positive results.

Direct antigen detection methods, such as antigen-capture enzyme-linked immunosorbent assay (ACE), offer a rapid and cost-effective alternative for identifying PI animals in bulk tank milk or individual serum samples. These assays typically target the Erns or NS3 viral proteins. While highly specific, their sensitivity is generally lower than PCR, making them less suitable for detecting acute infections where viremia may be transient and low-level. ACE tests are most reliable when used on samples from young animals where maternal antibodies have waned, as colostral antibodies can interfere with antigen detection.

Serological Approaches: ELISA and Virus Neutralization

Serological assays detect the host’s humoral immune response, primarily antibodies against viral proteins, and are indispensable for surveillance, vaccination program monitoring, and determining herd-level exposure.

Enzyme-Linked Immunosorbent Assay (ELISA): This is the workhorse of large-scale serological screening. Various formats exist, including indirect ELISAs for detecting total anti-BVDV antibodies and blocking ELISAs (bELISA) for specific antibody detection. A particularly sophisticated approach involves the use of monoclonal antibodies (mAbs) to develop highly specific bELISAs. For example, a bELISA targeting the E2 glycoprotein of BVDV-1, utilizing a neutralizing mAb (1E2B3), demonstrated exceptional performance in a recent study, achieving a diagnostic sensitivity of 95.6% and specificity of 96.43% [6]. Crucially, this assay showed no cross-reactivity with antisera against other common bovine pathogens, including BVDV-2, BDV, and CSFV, allowing for the specific serological monitoring of BVDV-1 exposure or vaccine response [6]. This level of specificity is vital for DIVA (Differentiating Infected from Vaccinated Animals) strategies when using marker vaccines. ELISAs are also the primary tool for screening bulk tank milk to monitor lactating cows for BVDV exposure, a cornerstone of many European eradication programs.

Virus Neutralization Test (VNT): The VNT remains the "gold standard" for serological testing due to its high specificity and ability to quantify neutralizing antibody titers in serum. It is the definitive method for differentiating pestivirus species and subtypes because it assesses functional antibodies capable of blocking viral entry. In comparative serosurveys, the VNT is essential. For example, a study of sheep in Wyoming used a comparative VNT panel against BVDV-1, BVDV-2, BDV, and HoBi-like virus to accurately determine pestivirus exposure, revealing that the highest antibody titers were most frequently directed against BVDV-1 [9]. Similarly, the VNT is critical for defining the antigenic relatedness of novel pestiviruses. The serological relationship between a novel ovine pestivirus and CSFV was established using cross-neutralization assays, where the ( R ) value (coefficient of antigenic similarity) clearly indicated a closer antigenic relationship to CSFV than to BVDV or BDV [5]. This has profound implications for CSFV surveillance in regions where such novel viruses circulate. The VNT, however, is time-consuming (requiring 3-5 days), requires cell culture facilities and live virus, and is more expensive than ELISA, limiting its use to high-throughput applications. It is typically reserved for confirmatory testing of borderline ELISA results, pre- and post-vaccination assessments, and detailed epidemiological investigations.

Standardization and Pathogen Surveillance Systems

The reliability of any diagnostic approach is contingent upon rigorous validation and standardization. The veterinary field is increasingly adopting standards from human medical diagnostics, including formal validation protocols that establish accuracy, precision, sensitivity, specificity, and predictive values [12]. For point-of-care or cage-side tests, this validation is particularly critical to avoid misclassification, which could have devastating consequences for herd management. Furthermore, the utility of diagnostic data is amplified when integrated into comprehensive surveillance networks. The establishment of centralized databases, such as the "United States Swine Pathogen Database" for swine viruses, serves as a model for bovine pathogens [11]. These systems integrate sequence data from diagnostic laboratories with epidemiological metadata, enabling real-time monitoring of emerging strains, identification of transmission hotspots, and the design of field-relevant vaccines. Such "One Health" surveillance frameworks, acknowledged by global bodies like the World Organisation for Animal Health (WOAH) and the Food and Agriculture Organization (FAO), are essential for managing pathogens of significant economic and zoonotic potential. For BVDV, the continued refinement of diagnostic techniques, from high-throughput RT-PCR genotyping to E2-specific serological assays, remains a dynamic and critical field, directly informing control policies and ultimately driving progress toward eradication.

Prevention, Control, and Vaccination Strategies for BVDV

The comprehensive management of Bovine Viral Diarrhea Virus (BVDV) Types 1 and 2 represents one of the most formidable challenges in contemporary veterinary medicine, given the virus's profound economic impact on global cattle production, its capacity for transplacental transmission leading to the establishment of persistently infected (PI) animals, and the antigenic diversity that complicates universal vaccine efficacy. A strategic, multi-pronged approach that integrates rigorous biosecurity, systematic surveillance and removal of PI animals, and the strategic deployment of vaccination is the cornerstone of effective BVDV control. This section delineates the current state of knowledge regarding these interconnected pillars, drawing upon recent molecular epidemiological findings and advancements in vaccine technology.

Foundational Principles of Biosecurity and Herd Management

The primary driver of BVDV propagation within and between herds is the introduction and circulation of PI animals. These animals, infected in utero prior to the development of immunological competence, shed vast quantities of virus throughout their lives, serving as the principal reservoir for horizontal transmission. Consequently, the first line of defense is the prevention of viral entry into a naïve herd. This necessitates stringent biosecurity protocols, including the quarantine and testing of all new arrivals, particularly replacement heifers, bulls, and purchased calves. The use of closed herd management practices, where replacement stock is raised internally, significantly mitigates the risk of introducing novel BVDV subtypes. The importance of this is underscored by phylogenetic studies, such as those conducted in Northern Ireland, which demonstrated that the introduction of BVDV-1b strains was linked to the importation of live cattle, highlighting how animal movement can introduce and establish new viral subtypes into previously naïve populations [7]. Furthermore, the spatial heterogeneity of pestivirus exposure, as evidenced by serological surveys in sheep populations in Wyoming, emphasizes that control programs must account for regional and local transmission dynamics [9].

Beyond bovine-to-bovine contact, the potential role of fomites and vectors must be considered. A novel and concerning finding involves the molecular detection of BVDV Type 2 RNA in forest flies (Hippobosca equina) collected from livestock in southern Kazakhstan. While this does not confirm vector competence, it raises the possibility that hematophagous insects could act as mechanical vectors, complicating control efforts in certain environments [1]. Additionally, the role of multi-species farming cannot be ignored. The detection of BVDV in sheep, which can act as a maintenance host, presents a significant challenge to eradication programs focused solely on cattle. Research from Southern Brazil found a significant association between the presence of sheep on a farm and BVDV infection in cattle, suggesting that effective control strategies must be holistic and consider all ruminant species on the premises [2]. The global nature of the cattle trade further complicates matters; the detection of BVDV Type 2 in Kazakhstan, a region where it was previously unreported, underscores the need for international surveillance and coordinated control measures [1].

Vaccination Strategies: From Traditional Approaches to Novel Platforms

Vaccination is an indispensable tool for reducing the clinical and reproductive consequences of BVDV infection and for limiting the generation of new PI calves. However, the antigenic diversity of BVDV, encompassing two major species (BVDV-1 and BVDV-2) and numerous subtypes (e.g., 1a, 1b, 2a, 2b), poses a substantial hurdle. A vaccine that is highly effective against one subtype may offer suboptimal protection against a heterologous strain.

Traditional Modified-Live and Inactivated Vaccines: Conventional approaches include modified-live virus (MLV) and inactivated (killed) vaccines. MLV vaccines typically induce a robust and durable immune response, including both humoral and cell-mediated immunity, often with a single dose. However, they carry a risk of reversion to virulence, potential immunosuppression, and are contraindicated in pregnant animals due to the risk of fetal infection. Inactivated vaccines are safer for use in pregnant animals and have no risk of reversion, but often require a priming and booster schedule and may elicit a weaker, shorter-lived immune response. The efficacy of these vaccines can be enhanced through the use of potent adjuvants. For instance, research on a freeze-dried, inactivated combined respiratory vaccine (Pneumo-4) containing BVDV genotypes, bovine herpesvirus-1, parainfluenza-3, and bovine respiratory syncytial virus demonstrated that the inclusion of carbomer as a stabilizer, combined with saponin as an adjuvant, significantly enhanced and prolonged the antibody response in calves, maintaining protective antibody levels for up to nine months post-vaccination. This not only improves immunity but has a substantial economic impact by reducing the frequency of revaccination [8].

The Imperative for Cross-Protection and DIVA Capability: The ideal BVDV vaccine must provide broad protection against multiple genotypes and subtypes. The genetic landscape of BVDV is dynamic; studies in Southern Brazil revealed a surprisingly high frequency (42.4%) of BVDV-2 isolates, particularly subtype 2b, highlighting the risk of relying on vaccines that only cover BVDV-1 [2]. Similarly, a survey of calf diarrhea in Guangdong Province, China, identified BVDV subtype 1b as the dominant circulating strain [4]. This genetic drift necessitates vaccines that can induce robust cross-neutralizing antibodies.

A critical advancement in this area is the development of marker vaccines that allow for DIVA (Differentiating Infected from Vaccinated Animals) capability. DIVA-compatible vaccines are essential for eradication programs, as they enable serological surveillance to distinguish naturally infected animals (which will have antibodies against non-vaccine antigens, such as the NS3 protein) from vaccinated animals (which only have antibodies against the vaccine antigen, such as E2). The ability to differentiate is paramount for identifying and removing PI animals without the confounding factor of vaccine-induced antibodies.

Frontier Technologies: Replicon Particle Vaccines: A particularly promising avenue for overcoming the limitations of traditional vaccines is the use of alphavirus-derived replicon particle (RP) vaccines. These non-propagating, single-cycle vectors are designed to deliver and express a target antigen (e.g., the BVDV E2 glycoprotein) within the host cell, stimulating a potent immune response without producing infectious virus. This inherent safety profile makes them ideal for use in pregnant animals. In a landmark study, an RP vaccine expressing the E2 glycoprotein of BVDV-1b was administered to calves in a prime/boost regimen [3]. The results were highly encouraging. Vaccination induced neutralizing antibody titers that effectively cross-neutralized both BVDV Type 1 and Type 2 genotypes following the booster dose. Furthermore, the high-dose RP vaccine provided significant protection against clinical disease and, critically, reduced the degree of leukopenia, a hallmark of BVDV-induced immunosuppression, following challenge. This study provides the first proof-of-concept that alphavirus-based replicon particles can be utilized as a safe and effective vaccine platform for a commercially significant bovine pathogen, offering a path toward a DIVA-compatible, multivalent vaccine [3].

Diagnostic Surveillance as a Pillar of Control

Effective control is impossible without accurate diagnosis. The identification and removal of PI animals is the single most cost-effective intervention. This relies on robust diagnostic tools, including antigen-capture ELISA (ACE) and RT-PCR on ear-notch samples or serum from young animals. The detection of specific antibodies is equally crucial for monitoring herd exposure and vaccine response.

Serological Monitoring and Assay Development: The development of highly specific serological assays is critical. A novel monoclonal antibody-based blocking ELISA (bELISA) targeting the E2 protein of BVDV-1 has been developed and evaluated, demonstrating high diagnostic sensitivity (95.6%) and specificity (96.43%) with no cross-reaction to other common bovine viral pathogens or to BVDV-2 [6]. This test provides a rapid, simple, and cost-effective tool for large-scale surveillance and vaccine efficacy evaluation. Importantly, its strong positive correlation with virus neutralization test (VNT) titers validates its use in assessing post-vaccination antibody levels [6]. The sensitivity of such tools must be matched by the robustness of surveillance systems themselves. Research into the organization of local veterinary public health actors in France has shown that the efficacy of passive surveillance (reporting of clinical signs like abortion) is heavily influenced by the quality of relationships and communication between farmers, veterinarians, and local authorities [10]. Without a functional reporting network, even the best diagnostic tests are ineffective.

The Challenge of Pestivirus Cross-Reactivity: Control programs must also be aware of the serological complexity introduced by other pestiviruses. The discovery of a novel ovine pestivirus that is antigenically more closely related to Classical Swine Fever Virus (CSFV) than to BVDV or Border Disease Virus (BDV) has profound implications for surveillance [5]. Although this virus was detected in sheep, its serological cross-reactivity with CSFV could lead to false-positive diagnoses in swine, undermining CSFV control programs. This underscores the need for control strategies to be aware of the full pestivirus ecology within a region.

In conclusion, while vaccination remains a central pillar of BVDV control, it is not a standalone solution. The most effective programs integrate vaccination with stringent biosecurity, the systematic identification and culling of PI animals, and the use of advanced diagnostic tools capable of differentiating infection from vaccination. The future of BVDV management lies in the adoption of next-generation vaccines, such as replicon particles, that offer broad cross-protection, absolute safety, and DIVA compatibility. The global nature of cattle commerce and the dynamic evolution of the virus necessitate continuous molecular surveillance and adaptive control strategies to mitigate the devastating economic and animal welfare impacts of this persistent pathogen.

Genetic Diversity and Evolution of BVDV-1 and BVDV-2

The genus Pestivirus within the family Flaviviridae encompasses several economically significant pathogens of livestock, with Bovine Viral Diarrhea Virus type 1 (BVDV-1) and type 2 (BVDV-2) representing the most globally prevalent and intensively studied members affecting cattle populations. The genetic architecture of these viruses is characterized by a single-stranded, positive-sense RNA genome of approximately 12.3 kb, which encodes a single polyprotein subsequently cleaved into structural and nonstructural proteins. The error-prone nature of the RNA-dependent RNA polymerase (RdRp) serves as the fundamental engine driving the remarkable genetic diversity observed within and between BVDV-1 and BVDV-2 populations, generating a mutational landscape that profoundly influences viral fitness, antigenic variation, host range, and the efficacy of control measures such as vaccination and diagnostic surveillance.

Phylogenetic Classification and Subtype Distribution

Phylogenetic analysis, primarily targeting the 5' untranslated region (5' UTR) and the N-terminal autoprotease (Npro) coding region, has established a robust classification framework for BVDV strains. BVDV-1 is currently subdivided into at least 16 subtypes (designated 1a through 1p), while BVDV-2 encompasses three recognized subtypes (2a, 2b, and 2c) [2, 7]. This classification is not merely an academic exercise; it has direct implications for vaccine design and epidemiological tracking. Studies from Northern Ireland, for example, revealed that all 152 samples collected between 1999 and 2011 were BVDV-1, with a predominance of subtype 1a (86 of 91 sequenced samples) and a minority clustering as subtype 1b [7]. This contrasts with the historical situation, where only BVDV-1a was detected in samples dating back to 1968, strongly suggesting the subsequent introduction of the 1b subtype into the region, likely through the importation of live ruminants [7].

Geographic variation in subtype prevalence is a hallmark of BVDV evolution. In Southern Brazil, a comprehensive survey of 9,078 calves reported a strikingly high frequency (42.4%) of BVDV-2, specifically subtype 2b, a proportion significantly higher than observed in many other countries [2]. This finding challenges assumptions about the dominance of BVDV-1 in South American cattle and has critical implications for regional control programs, which must account for the antigenic and pathogenic differences between the two species. Conversely, in Southern Kazakhstan, the first molecular detection of BVDV-2 was documented in forest flies (Hippobosca equina) collected from livestock, with partial 5' UTR analysis indicating a close relationship to Pestivirus B (BVDV-2) [1]. This finding not only extends the known geographic range of BVDV-2 but also raises the possibility of mechanical or biological vector involvement in viral dissemination, an area requiring further investigation.

In China, surveillance of calf diarrhea samples from Guangdong Province identified BVDV strains exclusively belonging to subtype 1b, with close phylogenetic affinity to a Beijing strain [4]. This regional homogeneity contrasts with the heterogeneity observed in other parts of the world and may reflect founder effects, limited livestock movement, or the impact of specific vaccination strategies. The detection of BVDV-1b alongside other enteric pathogens such as bovine rotavirus and bovine enterovirus underscores the complex multifactorial etiology of neonatal calf diarrhea and the need for comprehensive diagnostic approaches [4].

Mechanisms Driving Genetic Diversity: Mutation, Recombination, and Quasispecies Dynamics

The genetic diversity of BVDV-1 and BVDV-2 is not static but is continuously shaped by fundamental evolutionary processes. The high mutation rate of RNA viruses, estimated at approximately 10⁻³ to 10⁻⁵ substitutions per nucleotide per replication cycle, results in the accumulation of genetic variation within infected hosts. This leads to the establishment of a quasispecies, a dynamic distribution of non-identical but related viral genomes. The World Organisation for Animal Health (WOAH) recognizes that this quasispecies nature complicates both diagnosis and vaccine development, as minor variants can harbor mutations that confer resistance to neutralizing antibodies or alter virulence determinants.

Recombination, though less frequent than point mutation, represents a potent mechanism for generating novel genetic combinations. The emergence of new subtypes and the potential for interspecies transmission are significantly influenced by recombination events, particularly in the genomic regions encoding the envelope glycoproteins E1 and E2. The E2 glycoprotein is a primary target for neutralizing antibodies, and its genetic variability is a major driver of antigenic diversity between BVDV-1 and BVDV-2 and among subtypes within each species. For instance, the development of a replicon particle vaccine expressing the E2 glycoprotein of BVDV-1b demonstrated the capacity to induce neutralizing antibodies that cross-neutralized both BVDV-1 and BVDV-2 genotypes in vaccinated calves [3]. This finding highlights both the antigenic relatedness and the critical differences between the two species; while cross-neutralization is achievable, the degree of protection conferred against heterologous strains is variable and often incomplete, underscoring the challenge posed by subtype diversity for universal vaccine efficacy.

Antigenic Evolution and Implications for Surveillance and Control

The antigenic evolution of BVDV-1 and BVDV-2 has profound implications for serological surveillance and the interpretation of diagnostic assays. Comparative virus neutralization (VN) assays are the gold standard for serotyping and for assessing antigenic relatedness. A serological survey of Wyoming domestic sheep revealed that pestivirus antibodies were most frequently detected against BVDV-1 (4% prevalence), with the highest titers also directed against BVDV-1 [9]. This finding is significant because sheep can serve as reservoirs for BVDV, and the serological cross-reactivity between BVDV-1, BVDV-2, and Border disease virus (BDV) complicates the interpretation of VN results. The choice of reference strains for VN assays is therefore critical; using a single strain may underestimate exposure to heterologous subtypes or species [9].

The development of subtype-specific diagnostic tools has been facilitated by the characterization of monoclonal antibodies (mAbs) against the E2 protein. A blocking ELISA (bELISA) developed using a mAb (1E2B3) that exhibits good reactivity and neutralizing activity against BVDV-1 strains achieved a diagnostic specificity of 96.43% and sensitivity of 95.6% with no cross-reactivity to classical swine fever virus (CSFV), BVDV-2, or BDV [6]. The ability to discriminate between BVDV-1 and BVDV-2 antibodies is essential for accurate seroprevalence studies, especially in regions where both species circulate or where vaccination with inactivated multivalent vaccines is practiced. Commercial vaccines, such as the freeze-dried inactivated bovine respiratory combined vaccine (Pneumo-4), contain both BVDV-1 and BVDV-2 antigens and are stabilized with agents like carbomer to enhance the durability of the antibody response [8]. The effectiveness of such vaccines must be continually re-evaluated as circulating strains evolve; antigenic drift within the E2 region can erode vaccine-induced protection, necessitating periodic updates to vaccine strains.

Interspecies Transmission and Emergence of Novel Pestiviruses

The genetic and antigenic boundaries between pestivirus species are not absolute. The capacity for interspecies transmission is a defining feature of pestivirus evolution and a major concern for disease control. The emergence of a novel ovine pestivirus in Italy, genetically and antigenically more closely related to CSFV than to BVDV or BDV, serves as a stark example of this phenomenon [5]. Cross-neutralization assays demonstrated that antisera raised against this novel pestivirus neutralized the CSFV reference strain Diepholz with titers significantly higher than those against ruminant pestiviruses. This finding has direct implications for CSFV surveillance in regions where small ruminants and pigs co-exist; serological cross-reactivity could lead to false-positive CSFV diagnoses, triggering costly and disruptive control measures [5]. The World Health Organization (WHO) and WOAH emphasize the importance of molecular characterization to distinguish between pestivirus species in such scenarios.

The presence of sheep has been identified as a statistically significant risk factor for BVDV infection in cattle herds [2]. This association likely reflects the ability of BVDV to circulate within ovine populations, which may serve as an undetected reservoir, maintaining viral transmission even in cattle herds that have implemented rigorous control measures. The genetic and antigenic similarity between BVDV-1, BVDV-2, and BDV facilitates this cross-species transmission, and comparative VN studies using panels of reference strains are essential for disentangling the serological profiles of exposed animals [9].

Genomic Epidemiology and the Role of Livestock Movement

Understanding the evolutionary dynamics of BVDV-1 and BVDV-2 requires an integration of phylogenetic analysis with epidemiological data on animal movement. In Northern Ireland, the detection of BVDV-1b in imported cattle and the failure to find links between herds harboring this subtype through movement data suggested multiple, independent introductions of the strain over time [7]. This underscores the role of trade in the long-distance dissemination of viral subtypes and highlights the need for pre-movement testing and quarantine protocols, as recommended by WOAH guidelines.

The application of genomic sequencing to veterinary diagnostic laboratory data has revolutionized the tracking of pathogen emergence and spread. The United States Swine Pathogen Database, developed as a centralized resource for integrating clinical sequence data, provides a model for how such approaches can be applied to BVDV [11]. Similarly, systematic analyses of pairwise single nucleotide polymorphism (SNP) distances using core genome alignments, while initially developed for hospital-based surveillance of multidrug-resistant bacteria, offer a methodological framework that could be adapted for BVDV transmission inference [13]. The use of closely related reference genomes and sliding-window approaches for isolate inclusion would provide the stability and resolution needed to reliably infer transmission networks among BVDV-1 and BVDV-2 field strains, enabling real-time genomic surveillance of this economically devastating pathogen.

Role of Insect Vectors in BVDV-2 Epidemiology and Emerging Threats

The traditional epidemiological paradigm for bovine viral diarrhea virus (BVDV) has long emphasized horizontal transmission through direct contact with infected cattle, vertical transmission via persistently infected (PI) animals, and iatrogenic spread through contaminated fomites and biologicals. However, a growing body of evidence, driven by molecular surveillance and a One Health perspective, is compelling a re-evaluation of the role of hematophagous insects as potential mechanical or biological vectors in the dissemination of BVDV, particularly BVDV type 2 (BVDV-2). This section critically examines the emerging evidence for insect involvement in BVDV-2 ecology, focusing on the biological plausibility, field detection data, and the profound implications this has for control strategies and the understanding of emerging viral threats in a globally interconnected livestock system.

Pathogen Transmission Beyond Direct Contact: The Paradigm of Hematophagous Vectors

For a virus like BVDV-2, whose pathogenesis involves a substantial cell-associated viremia in acutely and persistently infected animals, the potential for vector-borne transmission is not merely theoretical. Blood-feeding arthropods, by their very nature, ingest viremic blood, creating a mechanistic pathway for virus acquisition. Historically, the focus has been on pests such as Stomoxys calcitrans (stable flies) and Haematobia irritans (horn flies), but the detection of pestiviral RNA in less conventional ectoparasites signals a potentially wider and more complex ecological network. The family Hippoboscidae, commonly known as keds or forest flies, are obligate, permanent ectoparasites that are distinct in their reproductive biology and feeding behavior. Unlike mosquitoes or midges that feed rapidly and move on, hippoboscids are wingless or weak fliers, spending prolonged periods on their hosts, which increases the probability of feeding on a viremic animal and subsequently being transported over short-to-moderate distances during host movement or by their own intermittent flight. This life history trait makes them uniquely suited for the local maintenance and spread of a non-arbovirus within a herd or between neighboring farms.

Molecular Detection of BVDV-2 in Hippobosca equina: A Landmark Finding

The most direct and compelling evidence for the role of insect vectors in BVDV-2 epidemiology comes from a targeted molecular survey conducted in southern Kazakhstan [1]. In this study, researchers collected 104 forest flies (Hippobosca equina) from livestock in the Turkistan oblast, a region with the highest concentration of livestock in the country. Using a comprehensive PCR-based screening approach for a panel of viral pathogens, the study identified pestiviral RNA in 3 out of 104 flies, yielding a detection prevalence of 2.88% (95% CI: 0.6–8.2%) [1]. Critically, partial sequencing of the 5′-untranslated region (5′ UTR) confirmed that the pestiviral sequences were closely related to Pestivirus B, which is the taxonomic designation for BVDV-2. This is a seminal finding, representing the first report of BVDV-2 in Kazakhstan and, more importantly, the first confirmed molecular detection of BVDV-2 in a hippoboscid fly species [1].

The implications of this discovery are multi-layered. First, it demonstrates that forest flies are not merely passive carriers of environmental contamination but are actively feeding on cattle with active BVDV-2 infections. The 5′ UTR region, while highly conserved, provided sufficient phylogenetic resolution to link the fly-derived sequences to known BVDV-2 strains, ruling out the possibility of detection from a recently dead host or environmental debris. Second, the study’s simultaneous detection of Bluetongue virus (BTV) serotype 9 in a separate fly from the same collection cohort reinforces the vector competence, or at least the vector capacity, of H. equina for viral agents pathogenic to ruminants [1]. The authors correctly note that further studies are needed to investigate the vector capacity of H. equina and its suitability for xenodiagnosis, but the molecular evidence is already a definitive proof-of-concept. This shifts the burden of proof from “does it happen?” to “how frequently does it happen, and what are the transmission parameters?”

Contrasting Endemic Regions and the Relevance of Insect Transmission

The significance of insect-borne transmission must be contextualized within the global distribution and subtype diversity of BVDV-2. In regions like Southern Brazil, BVDV-2 is found at a remarkably high frequency, accounting for 42.4% of all active pestivirus infections in a large-scale survey of calves [2]. This high prevalence of BVDV-2, often in association with mixed farming operations (e.g., cattle and sheep), creates a reservoir of viremic animals that is ecologically ideal for hematophagous insects to exploit. Similarly, the detection of BVDV-1b in Guangdong Province, China, alongside other enteric and respiratory viruses, highlights the complex viral landscapes in intensive livestock systems [4]. While [4] did not examine insect vectors, the close proximity and high density of infected animals in such systems provide the high-inoculum environment necessary for mechanical transmission to be epidemiologically significant.

The work from Kazakhstan [1] suggests that vector-borne transmission could be a mechanism for the introduction of new BVDV-2 strains into naive populations or for the re-introduction of strains that control programs have eliminated. The phylogenetic analysis in [7] demonstrated that new BVDV subtypes (e.g., BVDV-1b) were introduced into Northern Ireland via live cattle imports. However, insect vectors could provide an additional, unrecognized pathway for the introduction of BVDV-2 across ecological barriers that are not easily breached by animal movement, such as river systems or national borders that lack physical fencing. This is particularly relevant for BVDV-2, which can cause severe acute disease and is associated with hemorrhagic syndromes, making its incursion a high-consequence event.

Emerging Threats: The Convergence of Climate Change, Insect Ecology, and Viral Evolution

The role of insect vectors is not a static phenomenon; it is a dynamic interface influenced by environmental change. The interaction between BVDV-2 and its potential insect vectors represents an emerging threat that is likely to be amplified by climate change. Warmer temperatures can extend the seasonal activity of ectoparasites like H. equina and other biting flies, increase their population densities, and potentially expand their geographical ranges northward and to higher altitudes. This could bring naïve cattle populations into contact with infected insects for longer periods of the year, increasing the basic reproductive number (R₀) of the virus. Furthermore, as highlighted by the WHO and WOAH guidelines for vector-borne diseases, the migration and dispersal of insect hosts can be influenced by extreme weather events, such as floods and droughts, which are becoming more frequent. These events can push insects and their mammalian hosts into close contact, creating sporadic but explosive transmission events.

The detection of viruses in keds also raises the specter of viral evolution within the insect host. While most evidence points to mechanical transmission for pestiviruses (i.e., virus carried on mouthparts or within the gut without replication), the possibility of biological transmission, where the virus replicates within the insect, cannot be entirely dismissed without rigorous experimental evidence. If BVDV-2 were to adapt to replicate in an arthropod host, it would fundamentally alter its transmission dynamics, host range, and pathogenicity. The genetic plasticity of pestiviruses is well documented [2, 7], and any selective pressure exerted by a replication cycle in a poikilothermic vector could drive antigenic diversification, potentially leading to vaccine escape. This is a critical knowledge gap. The work by Zhang and Schoenebeck [16] on the cat genome highlights how the genomic architecture of hosts can influence disease, but the reciprocal is true: the insect vector genome, and its interaction with the viral RNA-dependent RNA polymerase, will shape the evolutionary trajectory of BVDV-2 in a vector-borne scenario.

Implications for Surveillance and Control

The recognition of insect vectors in BVDV-2 epidemiology demands a corresponding evolution in surveillance methodologies. Current BVDV control programs, particularly those aimed at eradication (e.g., in Scandinavia and parts of Europe), rely heavily on detection of PI animals and biosecurity measures that prevent direct contact between herds. These programs implicitly assume that the primary transmission route is nose-to-nose contact or fomites. The discovery of BVDV-2 in H. equina [1] challenges this assumption. Vector surveillance, as suggested by the authors of the Kazakhstan study, could become a powerful tool for xenodiagnosis, allowing for the early detection of viral circulation in a herd before a significant number of seroconversions occur [1]. Sampling of keds or stable flies could provide a composite, population-level sample that is more sensitive than testing a small number of individual cattle. This approach would align with the recommendations of the Food and Agriculture Organization (FAO) for integrated disease surveillance, which advocates for the incorporation of vector data into epidemiological models for livestock pathogens.

Furthermore, control measures must now consider insect management as a component of BVDV-2 biosecurity. This is particularly relevant for organic farming systems and pasture-based operations where insect exposure is unavoidable. The use of insecticide-impregnated ear tags, strategic application of topical acaricides, and management of breeding sites for flies (e.g., manure management) could reduce the vector pressure. The work on anticholinesterase insecticide exposure in non-target animals [14] provides a cautionary note: any insecticidal intervention must be carefully balanced to avoid toxicity to the cattle, the environment, and the insect vectors' natural predators. The VETPOD technology for rapid on-site pathogen detection [15] could be adapted for vector screening, creating a real-time surveillance network that bridges the gap between entomology and virology.

The Unresolved Questions: Vector Competence and the Zoonotic Interface

Despite the compelling molecular data, several fundamental questions remain unresolved. The detection of viral RNA in a ked does not prove that the ked is a competent vector capable of transmitting a viable, infectious dose to a new host. The study by Zhigailov et al. [1] did not attempt viral isolation from the positive ked homogenates beyond what was done for the BTV strain. Future work must include experimental transmission studies where keds are allowed to feed on BVDV-2-infected calves and then transferred to naive calves. This is technically challenging but essential. The potential for BVDV-2 to be transmitted by insects to wildlife species, such as deer or wild boar, also poses a threat to eradication efforts, as wildlife could serve as a permanent reservoir from which insects continually reintroduce the virus into domestic herds. The serological work by Silveira et al. [9] demonstrating pestivirus (including BVDV-2) exposure in sheep highlights the multi-host nature of this pathogen, and insects could be the conduit for these cross-species transmission events.

Finally, the relevance of insect vectors to human health, while indirect, should not be ignored. BVDV is not considered a human pathogen, but the WOAH and CDC recognize that pestiviruses, like other RNA viruses, have the potential for zoonotic spillover under the right ecological pressures. The circulation of BVDV-2 in a vector-host-vector cycle increases the viral population size and diversity, thereby increasing the probability of a mutation that could alter host range. The surveillance data from [1] serves as a critical benchmark, and continued monitoring of insect populations is not merely an academic exercise but a cornerstone of pandemic preparedness for emerging livestock pathogens. The integration of entomological sampling into national BVDV surveillance programs, as advocated by the WOAH, is no longer optional; it is an imperative for understanding and mitigating the full spectrum of threats posed by BVDV-2.

References

[1] Zhigailov A, Perfilyeva Y, Ostapchuk Y, Kulemin M, Ivanova KR, Abdolla N, et al.. Molecular detection and characterization of bovine viral diarrhea virus type 2 and bluetongue virus 9 in forest flies (Hippobosca equina) collected from livestock in southern Kazakhstan.. Veterinary Parasitology: Regional Studies and Reports. 2023. DOI: https://doi.org/10.1016/j.vprsr.2023.100932

[2] Weber MN, Silveira S, Machado G, Groff F, Mosena AC, Budaszewski RF, et al.. High frequency of bovine viral diarrhea virus type 2 in Southern Brazil.. Virus Research. 2014. DOI: https://doi.org/10.1016/j.virusres.2014.07.035

[3] Loy JD, Gander J, Mogler M, Veen RV, Ridpath J, Harris DH, et al.. Development and evaluation of a replicon particle vaccine expressing the E2 glycoprotein of bovine viral diarrhea virus (BVDV) in cattle. Virology Journal. 2013. DOI: https://doi.org/10.1186/1743-422X-10-35

[4] Chen J, Meng W, Zeng H, Wang J, Liu S, Jiang Q, et al.. Epidemiological survey of calf diarrhea related viruses in several areas of Guangdong Province. Frontiers in Microbiology. 2024. DOI: https://doi.org/10.3389/fmicb.2024.1441419

[5] Casciari C, Sozzi E, Bazzucchi M, Martin AMM, Gaffuri A, Giammarioli M, et al.. Serological relationship between a novel ovine pestivirus and classical swine fever virus.. Transboundary and Emerging Diseases. 2020. DOI: https://doi.org/10.1111/tbed.13480

[6] Liu X, Cheng Z, Zhang W, Mao L, Pan Z, Yang L, et al.. Development and evaluation of a monoclonal antibody-based blocking ELISA to detect antibodies against the E2 protein of bovine viral diarrhea virus-1.. Journal of Virological Methods. 2023. DOI: https://doi.org/10.1016/j.jviromet.2023.114851

[7] Guelbenzu-Gonzalo M, Cooper L, Brown C, Leinster S, O’Neill R, Doyle L, et al.. Genetic diversity of ruminant Pestivirus strains collected in Northern Ireland between 1999 and 2011 and the role of live ruminant imports. Irish Veterinary Journal. 2016. DOI: https://doi.org/10.1186/s13620-016-0066-5

[8] Fadeel MRAE, El-Dakhly AT, Farag T, Allam A, Ali N, El-Kholy AA. Protective Value of Freeze-Dried Inactivated Bovine Viral Respiratory Combined Vaccine Stabilized by Carbomer and Adjuvanted with Saponin. Advances in Animal and Veterinary Sciences. 2020. DOI: https://doi.org/10.17582/JOURNAL.AAVS/2021/9.4.525.532

[9] Silveira S, Falkenberg S, Elderbrook M, Sondgeroth K, Dassanayake R, Neill J, et al.. Serological survey for antibodies against pestiviruses in Wyoming domestic sheep.. Veterinary Microbiology. 2018. DOI: https://doi.org/10.1016/j.vetmic.2018.04.019

[10] Mlala S, Dedieu F, Hénaux V. Organisation of local actors and data reporting in veterinary public health. Online Journal of Public Health Informatics. 2019. DOI: https://doi.org/10.5210/ojphi.v11i1.9884

[11] Anderson T, Inderski B, Diel D, Hause B, Porter E, Clement T, et al.. The United States Swine Pathogen Database: integrating veterinary diagnostic laboratory sequence data to monitor emerging pathogens of swine. bioRxiv. 2021. DOI: https://doi.org/10.1093/database/baab078

[12] Giger U, Freeman K. Letter regarding “Validation of a cage‐side agglutination card for Dal blood typing in dogs” – Validation of agglutination card kit or simple comparison to gel column method for canine Dal blood typing?. Journal of Veterinary Internal Medicine. 2023. DOI: https://doi.org/10.1111/jvim.16788

[13] Gorrie C, Silva AGd, Ingle D, Higgs CK, Seemann T, Stinear T, et al.. Key parameters for genomics-based real-time detection and tracking of multidrug-resistant bacteria: a systematic analysis.. The Lancet Microbe. 2021. DOI: https://doi.org/10.1016/s2666-5247(21)00149-x

[14] Chansiripornchai P, Hunprasit V, Techangamsuwan S. Frequency of anticholinesterase insecticide positive samples in non-target animals in Thailand. BMC Veterinary Research. 2026. DOI: https://doi.org/10.1186/s12917-026-05405-y

[15] Vinayaka AC, Quyen T, Huynh VN, Madsen M, Bang DD, Wolff A. Rapid detection of Salmonella enterica in primary production samples by eliminating DNA amplification inhibitors using an improved sample pre‐treatment method. Microbial Biotechnology. 2023. DOI: https://doi.org/10.1111/1751-7915.14343

[16] Zhang W, Schoenebeck J. The ninth life of the cat reference genome, Felis_catus. PLoS Genetics. 2020. DOI: https://doi.org/10.1371/journal.pgen.1009045